What happens when the Trump train hits the health care establishment? There’s no doubt that President-elect Trump’s decision to nominate Robert F. Kennedy Jr., an environmental activist and vaccine ...
In today's biotech news, Prime Editing's CEO promises aggressive defense of patents; Novartis acquires a gene editing startup, and the migration to Bluesky.